The combination of these three agents induced an immune-infiltrated tumor microenvironment with increased CD4+ and CD8+ T cells, and decreased TAMs and Treg cells, leading to improvement in the response of KP tumors to checkpoint inhibitors [49]. Here, CD8A is linked to neoplasm.